EGFR and posterior cortical atrophy: Moreover, a phase I/II adoptive T cell trial in 7 locally advanced and metastatic PCa patients using infusions of anti-CD3/anti-EGFR bispecific antibody armed activated T cells, induced anti-cancer cytotoxicity, and increased innate immune responses [178].